Genomic infectious disease diagnostics
kariusdx.com (opens in a new tab)Karius detects microbial cell-free DNA circulating in the bloodstream, using genomics and AI to give physicians diagnostic insight that supports rapid treatment decisions. The advantage is breadth from a single blood draw: conventional infectious disease diagnosis requires guessing at a pathogen and testing for it specifically, often through invasive sampling, which costs days that critically ill patients do not have. The company is expanding the rollout of its proprietary next-generation sequencing test across hospitals and health systems, working to optimise how infectious diseases are diagnosed and treated.
No current openings
Karius isn't hiring for Product, GTM, Sales, Marketing, BizOps, Data or Chief of Staff roles right now. We've tracked 17 roles here to date, and this page picks the next one up automatically.
Browse the full board